Eric Crombez
CIK 1653052 · EVP and Chief Medical Officer · last filed 2026-05-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.26M
Companies
3
Total Filings
21
Lifetime Open-Market Net
-$922.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABEO | Director | 37,313 | $7.45 | $278.0K | -$260.2K | 6 | 2026-05-15 |
| RARE | EVP and Chief Medical Officer | 111,189 | $26.80 | $2.98M | -$662.6K | 10 | 2026-05-06 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Chief Medical Officer | — | — | — | $0 | 3 | 2017-11-07 |
Recent Filings · Page 2 of 3
21 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-04 | RARE | Mixed | +22,839 | -$376.6K | EDGAR |
| 2025-02-03 | ABEO | Grant (A) | +36,101 | $0 | EDGAR |
| 2024-08-14 | ABEO | Grant (A) | +11,044 | $0 | EDGAR |
| 2024-05-03 | RARE | Sell (S) | −354 | -$15.5K | EDGAR |
| 2024-04-19 | RARE | Sell (S) | −142 | -$6.3K | EDGAR |
| 2024-03-05 | RARE | Mixed | +18,162 | -$66.6K | EDGAR |
| 2023-09-29 | RARE | Grant (A) | — | $0 | EDGAR |
| 2023-05-02 | RARE | Grant (A) | +4,658 | $0 | EDGAR |
| 2017-11-07 | Dimension Therapeutics, Inc. (DMTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2017-02-03 | Dimension Therapeutics, Inc. (DMTX) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.